Skip to main content

Animations

MJFF Publications

4401 - 4410 of 8761 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body Dementias
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011699
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Clinical Outcome and Striatal Dopaminergic Function After Shunt Surgery in Patients With Idiopathic Normal Pressure Hydrocephalus
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012064
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012342
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Olfactory Testing in Parkinson Disease and REM Behavior Disorder
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011743
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Quality Improvement in Neurology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012198
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000001036
    Citation Count: 96
  • Summary Details
    OPEN
    Title: COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
    Journal Name: Neurology Neuroimmunology & Neuroinflammation
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxi.0000000000001104
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000557
    Citation Count: 38
  • Summary Details
    RESTRICTED
    Title: How to Increase Diverse Representation in Parkinson's Disease Trials
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.